Trial Profile
Safety of ibrutinib in patients with B cell lymphoid malignancies: A real life cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia; Mantle-cell lymphoma
- Focus Adverse reactions
- 01 Sep 2016 New trial record